KSTP-TV

INTERVIEW: Breakthrough T1D walk

Minnesotans are trying to raise more than $1 million for type one diabetes, with the Breakthrough T1D walk in Eagan. The Breakthrough T1D Walk is set to take place on Saturday, May 17, at TCO Stadium ...
Becker's Hospital Review

U.S. FDA grants Breakthrough Therapy Designation for Roche’s investigational medicine ocrelizumab in primary progressive multiple sclerosis

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUSTM ...
Healio

FDA grants breakthrough therapy designation to tolebrutinib for MS

Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough therapy designation to an oral, investigational, brain-penetrant and bioactive ...
WGN Radio

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Designation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS) Tolebrutinib is the first and only brain-penetrant BTK ...